Summit Bridge Capital is the famous VC, which was founded in 2014. The company was established in Europe in Ireland. The main office of represented VC is situated in the Dublin.
For fund there is no match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Semiconductor, Health Care. Among the various public portfolio startups of the fund, we may underline Swrve, Novaerus, Accuris Networks Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Summit Bridge Capital, startups are often financed by Enterprise Ireland, Capital-E, Atlantic Bridge. The meaningful sponsors for the fund in investment in the same round are Atlantic Bridge, Ulster Bank Diageo Venture Fund, Sunny Optical Technology. In the next rounds fund is usually obtained by Investec, Enterprise Ireland, Atlantic Bridge.
The top activity for fund was in 2014. The higher amount of exits for fund were in 2019. Opposing the other organizations, this Summit Bridge Capital works on 12 percentage points less the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. Considering the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year.
| Fund Name | Location |
| Alpha Capital | Chicago, Illinois, United States |
| Compo Seven Capital | - |
| Epsilon Health | - |
| Harlequin Corporate Finance | England, Oxton, United Kingdom |
| Know Diabetes by Heart | - |
| Limulus Venture Partners | Massachusetts, Newton, United States |
| Mitsui Fudosan | Chiyoda, Japan |
| XR Invest | - |
| Zhejiang Huixian Venture Capital | China, Hangzhou, Zhejiang |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 